Skip to content

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07140757
Enrollment
50
Registered
2025-08-26
Start date
2025-08-18
Completion date
2030-12-31
Last updated
2026-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Risk, Papillary Thyroid Cancer, Radiofrequency Ablation

Brief summary

To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.

Detailed description

Primary Objectives • To evaluate thyroid nodule volume changes over time in participants undergoing RFA as part of clinical care Secondary Objectives * To establish the health-related quality of life among participants undergoing with ultrasound guided RFA. * To evaluate the sonographic features of thyroid nodules over time following ultrasound guided RFA. * To assess adverse events rates following ultrasound guided RFA.

Interventions

OTHERQuestionnaire

This questionnaire includes twenty-four questions covering patients complaints ranging from 0 to 4. Patients will be asked about the presence and severity of each item currently on the medical appointment.

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligibility Criteria 1. Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC 2. Participant is over 18 years and is either not a surgical candidate or has declined surgery. 3. Capable and willing to provide written informed consent 4. Participant has one of the following diagnoses: * Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment, * Biopsy-proven indeterminate nodules (AUS or follicular neoplasm) * Papillary thyroid carcinoma (PTC) without metastasis * Locally recurrent thyroid cancer (\< 2 cm).

Exclusion criteria

1. Participants meeting any of the following criteria will be excluded: 2. Participants considered unsuitable for RFA by the treating physician

Design outcomes

Primary

MeasureTime frameDescription
Health- related Quality of Life QuestionnairesThrough study completion; an average of 1 yearThis questionnaire includes twenty-four questions covering patients complaints ranging from 0 to 4. Patients will be asked about the presence and severity of each item currently on the medical appointment.

Countries

United States

Contacts

CONTACTVictoria E Banuchi, MD
vebanuchi@mdanderson.org346-217-8668
STUDY_DIRECTORVictoria E Banuchi, MD

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 17, 2026